Please login to the form below
Covidien
This page shows the latest Covidien news and features for those working in and with pharma, biotech and healthcare.
Medtronic's comms team triumphs at Communiqué 2016
momentous acquisition of Covidien. ... transition through the Medtronic and Covidien merger.”.
Latest news
-
Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase
Mallinckrodt itself was spun off from Covidien in 2013 and has used acquisitions as a way of further its growth.
-
Medical device M&A hit 'all-time high' in 2014
move was a tactical one, given Covidien's established status in the sector. ... Covidien has been expanding its business in patient monitoring and hospital services, including generating promising revenue.
-
Shire drawn into Luxembourg tax haven exposé
Other pharma companies appearing in an ICIJ database of leaked documents - related to tax rulings that have been approved by Luxembourg officials - include Abbott, Covidien, EUSA Pharma (now Jazz Pharmaceuticals), GE,
-
AbbVie rethinks Shire merger in light of US tax crackdown
Cayman Islands. 2014. Horizon. Vidarg. Ireland. Pending. Medtronic. Covidien. Ireland. Pending.
-
Pharma supports first World Thrombosis Day
The medical technology firm Covidien is also a global partner. Bayer is also a partner of Quality in Care Anticoagulation, an awards programme developed by PMLiVE publishers PMGroup to recognise good
More from news
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare (part 2)
The device has now been licensed to Covidien GI Solutions and is in late-stage trials for Barrett’s oesophagus.
-
Pharma deals during October 2014
Medtronic is also pressing ahead with its takeover of Covidien and, as in the case of Mylan, this deal has required restructuring with Medtronic borrowing $16bn in place of the cash
-
Pharma deals during September 2014
These new measures will impact deals that have not yet closed such as Medtronic's $43bn acquisition of Covidien and AbbVie's $54bn acquisition of Shire; renegotiation and/or restructuring the ... In the latter case, many deals contain sizeable break-up
-
Pharma deals during July 2014
Both Medtronic's $42.9bn takeover of Irish-based Covidien and Salix's merger with Cosmo have contingencies to allow the US companies to back out of their respective deals if
-
Deal Watch table for June 2014
Covidien/ Medtronic. Company acquisition. Medical device company adding US critical mass.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Dr Stephen Mascioli and Dana Alexander join Anika Therapeutics
Prior to joining Terumo, Dr Mascioli served as chief medical officer of the vascular therapies division of Covidien, a medical devices company, and has held leadership positions at Boston Scientific and
-
Baxter appoints Jose Almeida chairman and CEO
Almeida was the chief executive of Covidien, a global healthcare products company, until the company was acquired by Medtronic earlier this year.
-
Teva appoints Timothy Wright as business development head
The former Covidien Pharma president mostrecently led a US cancer centre. ... Prior to that Wright spent more than 25 years in pharma and biotech, most recently as president of Covidien Pharma from 2007-10.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Sanofi Global Health unveils new nonprofit Impact brand
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- The Power of AI in Medical Education
- First evidence-based guide launched to put patients at heart of digital innovations
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- New Swiss research reveals how Omicron evades the immune system
- Evoke Kyne Named Communiqué Communications Consultancy of the Year 2021
- Michael Grela Elected President of the Society for Health Communication
- First evidence-based guide launched to put patients at heart of digital innovations
- Roche shares new positive Ocrevus data for MS patients
- FDA grants Priority Review for Biogen and Eisai’s lecanemab for early Alzheimer’s disease
- A creative awakening – how pharma is bringing innovation to the patient journey
- Country report: The healthcare market in South Korea
- European Commission approves potential new treatment for Pompe disease
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Five big changes in the healthcare comms landscape
- The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
- Early communications in Pharma: How effective pre-approval comms delivers launch success
- What communications are required for a successful launch...
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
